Blog

Home/News/Valeant under investigation by SEC: Bloomberg

Valeant under investigation by SEC: Bloomberg

(Reuters) – Shares in embattled drugmaker Valeant Pharmaceuticals International Inc fell as much as 21 percent on Monday after Bloomberg reported that the company is under investigation by the U.S. Securities and Exchange Commision in a previously undisclosed probe.

    

Written by

Peter Zirbes, ESQ. A Full Service Law Office 718 544 6300